Cyrus Biotechnology

OverviewSuggest Edit

Cyrus is a biotechnology software company. It delivers scientifically advanced, powerful, and easy-to-use protein structure prediction and protein design software. The Company accelerates drug discovery at biotech firms, as well as new product development at synthetic biology, chemical and consumer products companies.

TypePrivate
Founded2014
HQSeattle, WA, US
Websitecyrusbio.com

Latest Updates

Employees (est.) (Jun 2021)21(-4%)
Cybersecurity ratingBMore

Key People/Management at Cyrus Biotechnology

Lucas Nivon

Lucas Nivon

Chief Executive Officer
David Baker

David Baker

Scientific Co-Founder & Advisor
Rosario Caltabiano

Rosario Caltabiano

Executive VP of Sales
Sam Deluca

Sam Deluca

Director of Engineering
Gus Tai

Gus Tai

Board Member
Eric Bell

Eric Bell

Board Member
Show more

Cyrus Biotechnology Office Locations

Cyrus Biotechnology has an office in Seattle
Seattle, WA, US (HQ)
500 Union St Suite 320
Seattle, WA, US
1201 2nd Ave #900
Show all (2)

Cyrus Biotechnology Financials and Metrics

Summary Metrics

Founding Date

2014

Cyrus Biotechnology total Funding

$8.9 m

Cyrus Biotechnology latest funding size

$8 m

Time since last funding

4 years ago

Cyrus Biotechnology investors

Cyrus Biotechnology's latest funding round in July 2017 was reported to be $8 m. In total, Cyrus Biotechnology has raised $8.9 m
Show all financial metrics

Cyrus Biotechnology Cybersecurity Score

Cybersecurity ratingPremium dataset

B

82/100

SecurityScorecard logo

Cyrus Biotechnology Online and Social Media Presence

Embed Graph

Cyrus Biotechnology Blogs

Scientific Summary: Cyrus NextGen Antibody structure prediction beats Schrodinger and others in a large independent benchmark

Over the last few years Cyrus has worked on problems on a range of proteins from enzymes to non-antibody biologics to vaccines to some antibody work. However most biologic drugs are monoclonal antibodies or variants thereof, and historically this has been a small share of our work, and an area where…

New Cyrus “NextGen” antibody software outperforms the competition in third party test with BIOCAD biotechnology

Summary Cyrus has developed a “NextGen” antibody structure prediction tool (NextGen) based on the RosettaCM “hybridize” algorithm (1). Cyrus customized and modified RosettaCM for antibody structures with an antibody-specific database, sequence parsing, and by taking antibody-specific heavy-light cha…

Use of Cyrus Bench cited in review article of human diseases caused by formin INF2 mutations

SEATTLE, WA July 13, 2020 — Cyrus Bench®, Cyrus Biotechnology, Inc.’s SaaS platform for protein engineering, has been used in a recent review article in Cellular and Molecular Life Sciences to correlate computationally predicted alterations in protein stability due to mutation with disease severity …

Prediction of protein mutational free energy: benchmark and sampling improvements increase classification accuracy

SEATTLE, WA March 20, 2020 — Software to predict the change in protein stability upon point mutation is a valuable tool for a number of biotechnological and scientific problems. To facilitate the development of such software and provide easy access to the available experimental data, the ProTherm da…

A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns — (Xconomy)

https://xconomy.com/national/2019/12/03/a-safer-crispr-cyrus-broad-institute-look-to-quell-concerns/ The post A Safer CRISPR? Cyrus, Broad Institute Look to Quell Concerns — (Xconomy) appeared first on Cyrus Biotech | Molecular Modeling and Design.

Cyrus, the Broad team up to make in vivo CRISPR use safer — (FierceBiotech)

https://www.fiercebiotech.com/biotech/cyrus-broad-team-up-to-make-vivo-crispr-use-safer The post Cyrus, the Broad team up to make in vivo CRISPR use safer — (FierceBiotech) appeared first on Cyrus Biotech | Molecular Modeling and Design.
Show more

Cyrus Biotechnology Frequently Asked Questions

  • When was Cyrus Biotechnology founded?

    Cyrus Biotechnology was founded in 2014.

  • Who are Cyrus Biotechnology key executives?

    Cyrus Biotechnology's key executives are Lucas Nivon, David Baker and Rosario Caltabiano.

  • How many employees does Cyrus Biotechnology have?

    Cyrus Biotechnology has 21 employees.

  • Who are Cyrus Biotechnology competitors?

    Competitors of Cyrus Biotechnology include Adaptimmune, Metabolon and Biopharm Services.

  • Where is Cyrus Biotechnology headquarters?

    Cyrus Biotechnology headquarters is located at 500 Union St Suite 320, Seattle.

  • Where are Cyrus Biotechnology offices?

    Cyrus Biotechnology has an office in Seattle.

  • How many offices does Cyrus Biotechnology have?

    Cyrus Biotechnology has 2 offices.